Cas:177211-26-6 1-(4-Chloro-2-fluoro-5-methylphenyl)ethanone manufacturer & supplier

Chemical Name:1-(4-Chloro-2-fluoro-5-methylphenyl)ethanone

CAS.NO:177211-26-6

Synonyms:Ethanone, 1-(4-chloro-2-fluoro-5-methylphenyl)-;1-acetyl-4-chloro-2-fluoro-5-methylbenzene;4-Chloro-2-fluoro-5-methylacetophenone;1-(4-Chloro-2-fluoro-5-methylphenyl)ethanone

Molecular Formula:C₉H₈ClFO

Molecular Weight:186.611

HS Code:2914700090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:258.4±35.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.512

PSA:17.07000

Exact Mass:186.024765

LogP:2.00

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Ethanone, 1-(4-chloro-2-fluoro-5-methylphenyl)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(4-Chloro-2-fluoro-5-methylphenyl)ethanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Chloro-2-fluoro-5-methylacetophenone Use and application,Ethanone, 1-(4-chloro-2-fluoro-5-methylphenyl)- technical grade,usp/ep/jp grade.

Related News: Tánaiste and Minister for Enterprise, Trade and Employment, Leo Varadkar TD welcomed the announcement, saying: “I’m really pleased that Ballina will play such an important role in the production of COVID-19 vaccines, which have saved millions of lives around the world. (2S,3R)-2,3-epoxy-2-methylbutanoic acid manufacturers Just last week, the CDC updated J&J’s label again to warn of “an increased risk” for GBS, although the agency has maintained that a definitive link hasn’t been established. Europe’s medicines regulator added its own warning on Thursday just ahead of ACIP’s meeting. (2E,4Z,6E,8E)-7-methyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal suppliers CHMP also recommended for approval Sanofi and Genzyme’s new Pompe disease drug, known in Europe as Nexviadyme (avalglucosidase alfa). Pompe disease is a rare, inherited disorder caused by the buildup of glycogen in the body’s cells. {Ni(OC6H3(3-Cl)CHO)2} vendor & factory CHMP also recommended for approval Sanofi and Genzyme’s new Pompe disease drug, known in Europe as Nexviadyme (avalglucosidase alfa). Pompe disease is a rare, inherited disorder caused by the buildup of glycogen in the body’s cells.,Just last week, the CDC updated J&J’s label again to warn of “an increased risk” for GBS, although the agency has maintained that a definitive link hasn’t been established. Europe’s medicines regulator added its own warning on Thursday just ahead of ACIP’s meeting.